References
Original Article
Seymour, J. F. et al. Venetoclax–rituximab in relapsed or refractory chronic lymphocytic leukemia. N. Engl. J. Med. 378, 1107–1120 (2018)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Killock, D. Venetoclax–rituximab holds substantial promise in CLL. Nat Rev Clin Oncol 15, 344–345 (2018). https://doi.org/10.1038/s41571-018-0017-z
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41571-018-0017-z
- Springer Nature Limited